Download PDF
Clin Colon Rectal Surg
DOI: 10.1055/s-0044-1791284
Review Article

Diverticulitis Management in Complex Medical Contexts

Laura E. Cooper
1   Department of Surgery, University of Maryland Medical Center, Baltimore, Maryland
,
Margaret S. Turlington
1   Department of Surgery, University of Maryland Medical Center, Baltimore, Maryland
,
Rebecca F. Brown
1   Department of Surgery, University of Maryland Medical Center, Baltimore, Maryland
› Author Affiliations
› Further Information
Also available at
   Permissions and Reprints

Abstract

Diverticulitis is a prevalent medical issue, particularly among elderly individuals in the Western world. Management is nuanced and is influenced by both disease presentation and patient factors, especially those that affect risk of septic and surgical complications. This paper reviews existing literature to explore the incidence, presentation, and management of diverticulitis in complex medical contexts—immunocompromised populations, specifically highlighting those undergoing chemotherapy, HIV/AIDS patients, transplant recipients, and individuals with autoimmune and connective tissue diseases. Not surprisingly, management of diverticulitis in these complex patient populations is associated with increased morbidity. However, even taking into consideration the risk of septic and surgical complications, more recent data and treatment recommendations suggest that both nonoperative and operative management strategies may be appropriate based on individual patient presentations, mirroring the treatment paradigm of immunocompetent patients. In addition, in discussing operative management of complex medical patients, immunosuppression alone should not be considered a contraindication to primary anastomosis. Overall, there are limited existing data on diverticulitis in immunocompromised populations and, especially, patients with autoimmune and connective tissue disorders. Further research is warranted to better understand the impact of these chronic diseases on diverticulitis severity and to best inform evidence-based practices in this complex clinical scenario.

Keywords

diverticulitis - operative management - immunocompromised - autoimmune disease


Publication History

Article published online:
11 October 2024

© 2024. Thieme. All rights reserved.

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

 

  • References

  • 1 Broad JB, Wu Z, Clark TG. et al. Diverticulosis and nine connective tissue disorders: epidemiological support for an association. Connect Tissue Res 2019; 60 (04) 389-398
    CrossrefPubMedSearch in Google Scholar
  • 2 Bollom A, Austrie J, Hirsch W. et al. Emergency department burden of diverticulitis in the USA, 2006-2013. Dig Dis Sci 2017; 62 (10) 2694-2703
    CrossrefPubMedSearch in Google Scholar
  • 3 Vather R, Broad JB, Jaung R, Robertson J, Bissett IP. Demographics and trends in the acute presentation of diverticular disease: a national study. ANZ J Surg 2015; 85 (10) 744-748
    CrossrefPubMedSearch in Google Scholar
  • 4 Klos CL, Bath NM, Carchman E. et al. Treating acute diverticulitis in pre- and post-solid-organ transplant patients: a single-institution cohort study. Colorectal Dis 2023; 25 (06) 1238-1247
    CrossrefPubMedSearch in Google Scholar
  • 5 Ahmadi N, Ahmadi N, Ravindran P, Kim TJ, Byrne CM, Young CJ. Acute diverticulitis in immunosuppressed patients: a 12-year management experience. ANZ J Surg 2023; 93 (09) 2161-2165
    CrossrefPubMedSearch in Google Scholar
  • 6 Serrano González J, Lucena de la Poza JL, Román García de León L. et al. Diverticulitis in immunodeficient patients: our experience in the management of high-risk patients. Rev Esp Enferm Dig 2020; 112 (01) 47-52
    PubMedSearch in Google Scholar
  • 7 Strate LL, Morris AM. Epidemiology, pathophysiology, and treatment of diverticulitis. Gastroenterology 2019; 156 (05) 1282-1298.e1
    CrossrefPubMedSearch in Google Scholar
  • 8 Siddharthan RV, Gardner IH, Lu KC. Diverticulitis in the immunocompromised patient. Semin Colon Rectal Surg 2019; 30 (03) 100689
    CrossrefPubMedSearch in Google Scholar
  • 9 Weizman AV, Nguyen GC. Diverticular disease: epidemiology and management. Can J Gastroenterol 2011; 25 (07) 385-389
    CrossrefPubMedSearch in Google Scholar
  • 10 Tartaglia D, Cremonini C, Annunziata E. et al; WIRES-T for Acute Diverticulitis Study Group. Acute diverticulitis in immunocompromised patients: evidence from an international multicenter observational registry (Web-based International Register of Emergency Surgery and Trauma, Wires-T). Tech Coloproctol 2023; 27 (09) 747-757
    PubMedSearch in Google Scholar
  • 11 Harpaz R, Dahl RM, Dooling KL. Prevalence of immunosuppression among US adults, 2013. JAMA 2016; 316 (23) 2547-2548
    CrossrefPubMedSearch in Google Scholar
  • 12 Hwang SS, Cannom RR, Abbas MA, Etzioni D. Diverticulitis in transplant patients and patients on chronic corticosteroid therapy: a systematic review. Dis Colon Rectum 2010; 53 (12) 1699-1707
    CrossrefPubMedSearch in Google Scholar
  • 13 Larson ES, Khalil HA, Lin AY. et al. Diverticulitis occurs early after lung transplantation. J Surg Res 2014; 190 (02) 667-671
    CrossrefPubMedSearch in Google Scholar
  • 14 Hall J, Hardiman K, Lee S. et al; Prepared on behalf of the Clinical Practice Guidelines Committee of the American Society of Colon and Rectal Surgeons. The American Society of Colon and Rectal Surgeons Clinical Practice Guidelines for the treatment of left-sided colonic diverticulitis. Dis Colon Rectum 2020; 63 (06) 728-747
    CrossrefPubMedSearch in Google Scholar
  • 15 Brandl A, Kratzer T, Kafka-Ritsch R. et al. Diverticulitis in immunosuppressed patients: a fatal outcome requiring a new approach?. Can J Surg 2016; 59 (04) 254-261
    CrossrefPubMedSearch in Google Scholar
  • 16 He S, Lu P, Etzioni D. et al. Management of acute diverticulitis in immunocompromised patients-the Mayo Clinic experience. Dis Colon Rectum 2023; 66 (03) 434-442
    CrossrefPubMedSearch in Google Scholar
  • 17 Samdani T, Pieracci FM, Eachempati SR. et al. Colonic diverticulitis in chemotherapy patients: should operative indications change? A retrospective cohort study. Int J Surg 2014; 12 (12) 1489-1494
    CrossrefPubMedSearch in Google Scholar
  • 18 U.S Statistics. HIV.gov. Updated August 15, 2024. Accessed January 8, 2024. https://www.hiv.gov/hiv-basics/overview/data-and-trends/statistics/
    PubMed
  • 19 Cronley K, Wenzke J, Hussan H. et al. Diverticulitis in HIV-infected patients within the United States. HIV Med 2016; 17 (03) 216-221
    CrossrefPubMedSearch in Google Scholar
  • 20 Ahmed A, Shaikh A, Rajwana Y, Ahlawat S. Effects of systemic lupus erythematosus on clinical outcomes and in-patient mortality among hospitalized patients with diverticulitis. Cureus 2022; 14 (07) e26603
    PubMedSearch in Google Scholar
  • 21 Organ donation from deceased donors continues 12-year record-setting trend. 2022 organ transplants again set annual records; organ donation from deceased donors continues 12-year record-setting trend. Organ Procurement & Transplant Network. Published January 10, 2023. Accessed January 8, 2024. https://optn.transplant.hrsa.gov/news/2022-organ-transplants-again-set-annual-records-organ-donation-from-deceased-donors-continues-12-year-record-setting-trend/#: ~:text=Deceased%20donation%20trends, recovered%20in%20a%20single%20year.
    PubMed
  • 22 Rencuzogullari A, Ozuner G, Binboga S, Aytac E, Krishnamurthi V, Gorgun E. Colonic diverticulosis and diverticulitis in renal transplant recipients: management and long-term outcomes. Am Surg 2017; 83 (03) 303-307
    CrossrefPubMedSearch in Google Scholar
  • 23 Sugrue J, Lee J, Warner C. et al. Acute diverticulitis in renal transplant patients: should we treat them differently?. Surgery 2018; 163 (04) 857-865
    CrossrefPubMedSearch in Google Scholar
  • 24 Lee JT, Skube S, Melton GB. et al. Elective colectomy for diverticulitis in transplant patients: is it worth the risk?. J Gastrointest Surg 2017; 21 (09) 1486-1490
    CrossrefPubMedSearch in Google Scholar
  • 25 Vaghiri S, Prassas D, Knoefel WT, Krieg A. Surgical management in immunosuppressed patients with sigmoid diverticulitis, still a challenge: a single-center observational study. Int J Colorectal Dis 2022; 37 (08) 1909-1917
    CrossrefPubMedSearch in Google Scholar
  • 26 Leganger J, Søborg MK, Mortensen LQ, Gregersen R, Rosenberg J, Burcharth J. Association between diverticular disease and Ehlers-Danlos syndrome: a 13-year nationwide population-based cohort study. Int J Colorectal Dis 2016; 31 (12) 1863-1867
    CrossrefPubMedSearch in Google Scholar
  • 27 Casey MC, Robertson I, Waters PS, Hanaghan J, Khan W, Barry K. Non-operative management of diverticular perforation in a patient with suspected Ehlers-Danlos syndrome. Int J Surg Case Rep 2014; 5 (03) 135-137
    CrossrefPubMedSearch in Google Scholar
  • 28 Rempenault C, Lukas C, Combe B. et al; French Society of Rheumatology and the investigators participating in AIR-PR, ORA and REGATE registries. Risk of diverticulitis and gastrointestinal perforation in rheumatoid arthritis treated with tocilizumab compared to rituximab or abatacept. Rheumatology (Oxford) 2022; 61 (03) 953-962
    CrossrefPubMedSearch in Google Scholar
  • 29 Curtis JR, Xie F, Chen L. et al. The incidence of gastrointestinal perforations among rheumatoid arthritis patients. Arthritis Rheum 2011; 63 (02) 346-351
    CrossrefPubMedSearch in Google Scholar
  • 30 Curtis JR, Lanas A, John A, Johnson DA, Schulman KL. Factors associated with gastrointestinal perforation in a cohort of patients with rheumatoid arthritis. Arthritis Care Res (Hoboken) 2012; 64 (12) 1819-1828
    CrossrefPubMedSearch in Google Scholar
  • 31 Leung C, Zahid A. Colonic perforation in polyarteritis nodosa with concurrent perforated sigmoid diverticulitis. Cureus 2022; 14 (01) e21509
    PubMedSearch in Google Scholar